A combination of metformin, a common diabetes drug, and clemastine, an antihistamine, can help repair myelin—the protective ...
The company was expecting a decision from the FDA by Sept. 28 for its oral drug tolebrutinib, but an update to the drug’s ...
Combining the diabetes medication metformin and the antihistamine clemastine increased myelin repair in people with RRMS, ...
A California federal judge has determined that biotech company Biogen owes Roche's Genentech more than $88 million in patent ...
Vidofludimus calcium currently is being evaluated in relapsing MS in two phase III trials, ENSURE-1 and ENSURE-2. The phase ...
On Monday, the U.S. Food and Drug Administration (FDA) extended the review date for Sanofi SA’s (NASDAQ:SNY) new drug ...
Those who prescribe larger amounts of MS drugs were more likely to have received payments, and those who got payments were ...
France's Sanofi said its Dupixent drug jointly developed with Regeneron advanced toward a new indication for chronic hives in the European Union, while the U.S. Food and Drug Administration extended ...